Загрузка...
Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis
PURPOSE OF REVIEW: The aim of this study was to describe the newest development in cystic fibrosis (CF) care, CF transmembrane conductance regulator (CFTR) modulator therapies. RECENT FINDINGS: Phase II results showing CFTR modulator triple therapies are more effective than current CFTR modulators....
Сохранить в:
| Опубликовано в: : | Curr Opin Pediatr |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6398332/ https://ncbi.nlm.nih.gov/pubmed/29538046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOP.0000000000000627 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|